FDA
approval
· 2021-03-04
FDA Approved: DESCOVY — Supplemental Application (Gilead Sciences, Inc.)
Summary
The FDA approved a supplemental application for DESCOVY (emtricitabine and tenofovir alafenamide) from Gilead, updating the product labeling per the supplementa…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DESCOVY (EMTRICITABINE AND TENOFOVIR ALAFENAMIDE)